{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:16:57Z","timestamp":1794320217309,"version":"4.9.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170318"],"award-info":[{"award-number":["82170318"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170381"],"award-info":[{"award-number":["82170381"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s11010-023-04830-z","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T16:02:07Z","timestamp":1693411327000},"page":"2105-2118","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Empagliflozin attenuates doxorubicin-impaired cardiac contractility by suppressing reactive oxygen species in isolated myocytes"],"prefix":"10.1007","volume":"479","author":[{"given":"Rong","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingze","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzeng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,30]]},"reference":[{"key":"4830_CR1","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/circulationaha.114.013777","volume":"131","author":"D Cardinale","year":"2015","unstructured":"Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni CA, Veglia F, Civelli M, Lamantia G, Colombo N, Curigliano G, Fiorentini C, Cipolla CM (2015) Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation 131:1981\u20131988. https:\/\/doi.org\/10.1161\/circulationaha.114.013777","journal-title":"Circulation"},{"key":"4830_CR2","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1002\/1097-0142(19850615)55:12<2761::aid-cncr2820551206>3.0.co;2-p","volume":"55","author":"AU Buzdar","year":"1985","unstructured":"Buzdar AU, Marcus C, Smith TL, Blumenschein GR (1985) Early and delayed clinical cardiotoxicity of doxorubicin. Cancer 55:2761\u20132765. https:\/\/doi.org\/10.1002\/1097-0142(19850615)55:12%3c2761::aid-cncr2820551206%3e3.0.co;2-p","journal-title":"Cancer"},{"key":"4830_CR3","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","volume":"37","author":"JL Zamorano","year":"2016","unstructured":"Zamorano JL, Lancellotti P, Rodriguez Mu\u00f1oz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GYH, Lyon AR, Lopez Fernandez T, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM (2016) 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 37:2768\u20132801. https:\/\/doi.org\/10.1093\/eurheartj\/ehw211","journal-title":"Eur Heart J"},{"key":"4830_CR4","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/1097-0142(1971)28:4<844::aid-cncr2820280407>3.0.co;2-9","volume":"28","author":"E Middleman","year":"1971","unstructured":"Middleman E, Luce J, Frei E 3rd (1971) Clinical trials with adriamycin. Cancer 28:844\u2013850. https:\/\/doi.org\/10.1002\/1097-0142(1971)28:4%3c844::aid-cncr2820280407%3e3.0.co;2-9","journal-title":"Cancer"},{"key":"4830_CR5","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1056\/nejm200004133421502","volume":"342","author":"GM Felker","year":"2000","unstructured":"Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK (2000) Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342:1077\u20131084. https:\/\/doi.org\/10.1056\/nejm200004133421502","journal-title":"N Engl J Med"},{"key":"4830_CR6","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1161\/circresaha.119.314681","volume":"126","author":"KB Wallace","year":"2020","unstructured":"Wallace KB, Sard\u00e3o VA, Oliveira PJ (2020) Mitochondrial determinants of doxorubicin-induced cardiomyopathy. Circ Res 126:926\u2013941. https:\/\/doi.org\/10.1161\/circresaha.119.314681","journal-title":"Circ Res"},{"key":"4830_CR7","doi-asserted-by":"publisher","first-page":"113903","DOI":"10.1016\/j.biopha.2022.113903","volume":"156","author":"Y Chen","year":"2022","unstructured":"Chen Y, Shi S, Dai Y (2022) Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy. Biomed Pharmacother 156:113903. https:\/\/doi.org\/10.1016\/j.biopha.2022.113903","journal-title":"Biomed Pharmacother"},{"key":"4830_CR8","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/circresaha.112.265819","volume":"111","author":"DA Kubli","year":"2012","unstructured":"Kubli DA, Gustafsson \u00c5B (2012) Mitochondria and mitophagy: the yin and yang of cell death control. Circ Res 111:1208\u20131221. https:\/\/doi.org\/10.1161\/circresaha.112.265819","journal-title":"Circ Res"},{"key":"4830_CR9","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1161\/circresaha.116.306374","volume":"116","author":"OS Shirihai","year":"2015","unstructured":"Shirihai OS, Song M, Dorn GW 2nd (2015) How mitochondrial dynamism orchestrates mitophagy. Circ Res 116:1835\u20131849. https:\/\/doi.org\/10.1161\/circresaha.116.306374","journal-title":"Circ Res"},{"key":"4830_CR10","unstructured":"Mohan UP, Kunjiappan S and Arunachalam S (2022) Doxorubicin Disrupts the Calcium Homeostasis through its Antagonistic Activity on PINK1\u2013An In-silico Approach."},{"key":"4830_CR11","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373:2117\u20132128. https:\/\/doi.org\/10.1056\/NEJMoa1504720","journal-title":"N Engl J Med"},{"key":"4830_CR12","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol 79:e263\u2013e421. https:\/\/doi.org\/10.1016\/j.jacc.2021.12.012","journal-title":"J Am Coll Cardiol"},{"key":"4830_CR13","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"4830_CR14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jchf.2022.03.006","volume":"10","author":"CA Gongora","year":"2022","unstructured":"Gongora CA, Drobni ZD, Silva TQAC, Zafar A, Gong J, Zlotoff DA, Gilman HK, Hartmann SE, Sama S, Nikolaidou S, Suero-Abreu GA, Jacobsen E, Abramson JS, Hochberg E, Barnes J, Armand P, Thavendiranathan P, Nohria A, Neilan TG (2022) Sodium-glucose co-transporter-2 inhibitors and cardiac outcomes among patients treated with anthracyclines. JACC Heart Fail 10:559\u2013567. https:\/\/doi.org\/10.1016\/j.jchf.2022.03.006","journal-title":"JACC Heart Fail"},{"key":"4830_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12933-020-01040-5","volume":"19","author":"J Sabatino","year":"2020","unstructured":"Sabatino J, De Rosa S, Tamm\u00e8 L, Iaconetti C, Sorrentino S, Polimeni A, Mignogna C, Amorosi A, Spaccarotella C, Yasuda M, Indolfi C (2020) Empagliflozin prevents doxorubicin-induced myocardial dysfunction. Cardiovasc Diabetol 19:66. https:\/\/doi.org\/10.1186\/s12933-020-01040-5","journal-title":"Cardiovasc Diabetol"},{"key":"4830_CR16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12933-021-01346-y","volume":"20","author":"V Quagliariello","year":"2021","unstructured":"Quagliariello V, De Laurentiis M, Rea D, Barbieri A, Monti MG, Carbone A, Paccone A, Altucci L, Conte M, Canale ML, Botti G, Maurea N (2021) The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin. Cardiovasc Diabetol 20:150. https:\/\/doi.org\/10.1186\/s12933-021-01346-y","journal-title":"Cardiovasc Diabetol"},{"key":"4830_CR17","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1161\/hh1101.091193","volume":"88","author":"SM Pogwizd","year":"2001","unstructured":"Pogwizd SM, Schlotthauer K, Li L, Yuan W, Bers DM (2001) Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res 88:1159\u20131167. https:\/\/doi.org\/10.1161\/hh1101.091193","journal-title":"Circ Res"},{"key":"4830_CR18","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.kint.2020.12.013","volume":"99","author":"RP Juni","year":"2021","unstructured":"Juni RP, Al-Shama R, Kuster DWD, van der Velden J, Hamer HM, Vervloet MG, Eringa EC, Koolwijk P, van Hinsbergh VWM (2021) Empagliflozin restores chronic kidney disease-induced impairment of endothelial regulation of cardiomyocyte relaxation and contraction. Kidney Int 99:1088\u20131101. https:\/\/doi.org\/10.1016\/j.kint.2020.12.013","journal-title":"Kidney Int"},{"key":"4830_CR19","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1161\/circulationaha.121.053889","volume":"144","author":"T Satoh","year":"2021","unstructured":"Satoh T, Wang L, Espinosa-Diez C, Wang B, Hahn SA, Noda K, Rochon ER, Dent MR, Levine AR, Baust JJ, Wyman S, Wu YL, Triantafyllou GA, Tang Y, Reynolds M, Shiva S, Hilaire CS, Gomez D, Goncharov DA, Goncharova EA, Chan SY, Straub AC, Lai YC, McTiernan CF, Gladwin MT (2021) Metabolic syndrome mediates ROS-miR-193b-NFYA-dependent downregulation of soluble guanylate cyclase and contributes to exercise-induced pulmonary hypertension in heart failure with preserved ejection fraction. Circulation 144:615\u2013637. https:\/\/doi.org\/10.1161\/circulationaha.121.053889","journal-title":"Circulation"},{"key":"4830_CR20","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.hrthm.2019.04.008","volume":"16","author":"L Jiang","year":"2019","unstructured":"Jiang L, Li L, Ruan Y, Zuo S, Wu X, Zhao Q, Xing Y, Zhao X, Xia S, Bai R, Du X, Liu N, Ma CS (2019) Ibrutinib promotes atrial fibrillation by inducing structural remodeling and calcium dysregulation in the atrium. Heart Rhythm 16:1374\u20131382. https:\/\/doi.org\/10.1016\/j.hrthm.2019.04.008","journal-title":"Heart Rhythm"},{"key":"4830_CR21","doi-asserted-by":"publisher","DOI":"10.3791\/62514","author":"K Wu","year":"2021","unstructured":"Wu K, Li LL, Li YK, Peng XD, Zhang MX, Liu KS, Wang XS, Yang JX, Wen SN, Ruan YF, Liu N, Bai R (2021) Modifications of the langendorff method for simultaneous isolation of atrial and ventricular myocytes from adult mice. J Vis Exp. https:\/\/doi.org\/10.3791\/62514","journal-title":"J Vis Exp"},{"key":"4830_CR22","doi-asserted-by":"publisher","first-page":"C1073","DOI":"10.1152\/ajpcell.00586.2006","volume":"293","author":"E Picht","year":"2007","unstructured":"Picht E, Zima AV, Blatter LA, Bers DM (2007) SparkMaster: automated calcium spark analysis with ImageJ. Am J Physiol Cell Physiol 293:C1073\u2013C1081. https:\/\/doi.org\/10.1152\/ajpcell.00586.2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"4830_CR23","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/europace\/eux271","volume":"20","author":"S Zuo","year":"2018","unstructured":"Zuo S, Li LL, Ruan YF, Jiang L, Li X, Li SN, Wen SN, Bai R, Liu N, Du X, Dong JZ, Ma CS (2018) Acute administration of tumour necrosis factor-\u03b1 induces spontaneous calcium release via the reactive oxygen species pathway in atrial myocytes. Europace 20:1367\u20131374. https:\/\/doi.org\/10.1093\/europace\/eux271","journal-title":"Europace"},{"key":"4830_CR24","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Brueckmann M, Jamal W, Kimura K, Schnee J, Zeller C, Cotton D, Bocchi E, B\u00f6hm M, Choi DJ, Chopra V, Chuquiure E, Giannetti N, Janssens S, Zhang J, Gonzalez Juanatey JR, Kaul S, Brunner-La Rocca HP, Merkely B, Nicholls SJ, Perrone S, Pina I, Ponikowski P, Sattar N, Senni M, Seronde MF, Spinar J, Squire I, Taddei S, Wanner C, Zannad F (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 383:1413\u20131424. https:\/\/doi.org\/10.1056\/NEJMoa2022190","journal-title":"N Engl J Med"},{"key":"4830_CR25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/toxres\/tfad007","volume":"12","author":"M Chen","year":"2023","unstructured":"Chen M (2023) Empagliflozin attenuates doxorubicin-induced cardiotoxicity by activating AMPK\/SIRT-1\/PGC-1\u03b1-mediated mitochondrial biogenesis. Toxicology Research 12:216\u2013223. https:\/\/doi.org\/10.1093\/toxres\/tfad007","journal-title":"Toxicology Research"},{"key":"4830_CR26","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.yjmcc.2011.07.016","volume":"51","author":"CM Sag","year":"2011","unstructured":"Sag CM, K\u00f6hler AC, Anderson ME, Backs J, Maier LS (2011) CaMKII-dependent SR Ca leak contributes to doxorubicin-induced impaired Ca handling in isolated cardiac myocytes. J Mol Cell Cardiol 51:749\u2013759. https:\/\/doi.org\/10.1016\/j.yjmcc.2011.07.016","journal-title":"J Mol Cell Cardiol"},{"key":"4830_CR27","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1006\/bbrc.1996.5898","volume":"230","author":"I M\u00fcller","year":"1997","unstructured":"M\u00fcller I, Jenner A, Bruchelt G, Niethammer D, Halliwell B (1997) Effect of concentration on the cytotoxic mechanism of doxorubicin\u2013apoptosis and oxidative DNA damage. Biochem Biophys Res Commun 230:254\u2013257. https:\/\/doi.org\/10.1006\/bbrc.1996.5898","journal-title":"Biochem Biophys Res Commun"},{"key":"4830_CR28","doi-asserted-by":"publisher","first-page":"9850","DOI":"10.1038\/s41598-019-46367-6","volume":"9","author":"S Ikeda","year":"2019","unstructured":"Ikeda S, Matsushima S, Okabe K, Ikeda M, Ishikita A, Tadokoro T, Enzan N, Yamamoto T, Sada M, Deguchi H, Morimoto S, Ide T, Tsutsui H (2019) Blockade of L-type Ca(2+) channel attenuates doxorubicin-induced cardiomyopathy via suppression of CaMKII-NF-\u03baB pathway. Sci Rep 9:9850. https:\/\/doi.org\/10.1038\/s41598-019-46367-6","journal-title":"Sci Rep"},{"key":"4830_CR29","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.yjmcc.2011.01.012","volume":"51","author":"ME Anderson","year":"2011","unstructured":"Anderson ME, Brown JH, Bers DM (2011) CaMKII in myocardial hypertrophy and heart failure. J Mol Cell Cardiol 51:468\u2013473. https:\/\/doi.org\/10.1016\/j.yjmcc.2011.01.012","journal-title":"J Mol Cell Cardiol"},{"key":"4830_CR30","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1161\/01.res.0000069686.31472.c5","volume":"92","author":"T Zhang","year":"2003","unstructured":"Zhang T, Maier LS, Dalton ND, Miyamoto S, Ross J Jr, Bers DM, Brown JH (2003) The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ Res 92:912\u2013919. https:\/\/doi.org\/10.1161\/01.res.0000069686.31472.c5","journal-title":"Circ Res"},{"key":"4830_CR31","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1161\/01.RES.0000258172.74570.e6","volume":"100","author":"J Curran","year":"2007","unstructured":"Curran J, Hinton MJ, R\u00edos E, Bers DM, Shannon TR (2007) Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium\/calmodulin-dependent protein kinase. Circ Res 100:391\u2013398. https:\/\/doi.org\/10.1161\/01.RES.0000258172.74570.e6","journal-title":"Circ Res"},{"key":"4830_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.yjmcc.2018.11.019","volume":"126","author":"A Llach","year":"2019","unstructured":"Llach A, Mazevet M, Mateo P, Villejouvert O, Ridoux A, Rucker-Martin C, Ribeiro M, Fischmeister R, Crozatier B, Benitah JP, Morel E, G\u00f3mez AM (2019) Progression of excitation-contraction coupling defects in doxorubicin cardiotoxicity. J Mol Cell Cardiol 126:129\u2013139. https:\/\/doi.org\/10.1016\/j.yjmcc.2018.11.019","journal-title":"J Mol Cell Cardiol"},{"key":"4830_CR33","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/ehf2.12336","volume":"5","author":"J Mustroph","year":"2018","unstructured":"Mustroph J, Wagemann O, L\u00fccht CM, Trum M, Hammer KP, Sag CM, Lebek S, Tarnowski D, Reinders J, Perbellini F, Terracciano C, Schmid C, Schopka S, Hilker M, Zausig Y, Pabel S, Sossalla ST, Schweda F, Maier LS, Wagner S (2018) Empagliflozin reduces Ca\/calmodulin-dependent kinase II activity in isolated ventricular cardiomyocytes. ESC Heart Fail 5:642\u2013648. https:\/\/doi.org\/10.1002\/ehf2.12336","journal-title":"ESC Heart Fail"},{"key":"4830_CR34","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1089\/ars.2020.8019","volume":"32","author":"V Sala","year":"2020","unstructured":"Sala V, Della Sala A, Hirsch E, Ghigo A (2020) Signaling pathways underlying anthracycline cardiotoxicity. Antioxid Redox Signal 32:1098\u20131114. https:\/\/doi.org\/10.1089\/ars.2020.8019","journal-title":"Antioxid Redox Signal"},{"key":"4830_CR35","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/ejhf.50","volume":"16","author":"CG Tocchetti","year":"2014","unstructured":"Tocchetti CG, Carpi A, Coppola C, Quintavalle C, Rea D, Campesan M, Arcari A, Piscopo G, Cipresso C, Monti MG, De Lorenzo C, Arra C, Condorelli G, Di Lisa F, Maurea N (2014) Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction. Eur J Heart Fail 16:358\u2013366. https:\/\/doi.org\/10.1002\/ejhf.50","journal-title":"Eur J Heart Fail"},{"key":"4830_CR36","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2008.02.048","volume":"133","author":"JR Erickson","year":"2008","unstructured":"Erickson JR, Joiner ML, Guan X, Kutschke W, Yang J, Oddis CV, Bartlett RK, Lowe JS, O\u2019Donnell SE, Aykin-Burns N, Zimmerman MC, Zimmerman K, Ham AJ, Weiss RM, Spitz DR, Shea MA, Colbran RJ, Mohler PJ, Anderson ME (2008) A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 133:462\u2013474. https:\/\/doi.org\/10.1016\/j.cell.2008.02.048","journal-title":"Cell"},{"key":"4830_CR37","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1161\/circresaha.110.221911","volume":"108","author":"S Wagner","year":"2011","unstructured":"Wagner S, Ruff HM, Weber SL, Bellmann S, Sowa T, Schulte T, Anderson ME, Grandi E, Bers DM, Backs J, Belardinelli L, Maier LS (2011) Reactive oxygen species-activated Ca\/calmodulin kinase II\u03b4 is required for late I(Na) augmentation leading to cellular Na and Ca overload. Circ Res 108:555\u2013565. https:\/\/doi.org\/10.1161\/circresaha.110.221911","journal-title":"Circ Res"},{"key":"4830_CR38","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/cvr\/cvaa123","volume":"117","author":"D Kolijn","year":"2021","unstructured":"Kolijn D, Pabel S, Tian Y, L\u00f3di M, Herwig M, Carrizzo A, Zhazykbayeva S, Kov\u00e1cs \u00c1, F\u00fcl\u00f6p G, Falc\u00e3o-Pires I, Reusch PH, Linthout SV, Papp Z, van Heerebeek L, Vecchione C, Maier LS, Ciccarelli M, Tsch\u00f6pe C, M\u00fcgge A, Bagi Z, Sossalla S, Hamdani N (2021) Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase G\u03b1 oxidation. Cardiovasc Res 117:495\u2013507. https:\/\/doi.org\/10.1093\/cvr\/cvaa123","journal-title":"Cardiovasc Res"},{"key":"4830_CR39","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.1093\/eurheartj\/ehab420","volume":"42","author":"H Kondo","year":"2021","unstructured":"Kondo H, Akoumianakis I, Badi I, Akawi N, Kotanidis CP, Polkinghorne M, Stadiotti I, Sommariva E, Antonopoulos AS, Carena MC, Oikonomou EK, Reus EM, Sayeed R, Krasopoulos G, Srivastava V, Farid S, Chuaiphichai S, Shirodaria C, Channon KM, Casadei B, Antoniades C (2021) Effects of canagliflozin on human myocardial redox signalling: clinical implications. Eur Heart J 42:4947\u20134960. https:\/\/doi.org\/10.1093\/eurheartj\/ehab420","journal-title":"Eur Heart J"},{"key":"4830_CR40","doi-asserted-by":"publisher","first-page":"1122494","DOI":"10.1155\/2022\/1122494","volume":"2022","author":"J Wang","year":"2022","unstructured":"Wang J, Huang X, Liu H, Chen Y, Li P, Liu L, Li J, Ren Y, Huang J, Xiong E, Tian Z, Dai X (2022) Empagliflozin ameliorates diabetic cardiomyopathy via attenuating oxidative stress and improving mitochondrial function. Oxid Med Cell Longev 2022:1122494. https:\/\/doi.org\/10.1155\/2022\/1122494","journal-title":"Oxid Med Cell Longev"},{"key":"4830_CR41","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s42003-023-04663-y","volume":"6","author":"J Choi","year":"2023","unstructured":"Choi J, Matoba N, Setoyama D, Watanabe D, Ohnishi Y, Yasui R, Kitai Y, Oomachi A, Kotobuki Y, Nishiya Y, Pieper MP, Imamura H, Yanagita M, Yamamoto M (2023) The SGLT2 inhibitor empagliflozin improves cardiac energy status via mitochondrial ATP production in diabetic mice. Commun Biol 6:278. https:\/\/doi.org\/10.1038\/s42003-023-04663-y","journal-title":"Commun Biol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04830-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-023-04830-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04830-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T15:20:27Z","timestamp":1724340027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-023-04830-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,30]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["4830"],"URL":"https:\/\/doi.org\/10.1007\/s11010-023-04830-z","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,30]]},"assertion":[{"value":"15 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The experimental procedures were performed in compliance with the Guide for the Care and Use of Laboratory Animals, proposed by the Institute of Animal Resources and published by the National Institute of Health (NIH Publication No. 85\u201323, revised 1996). The use of animals in this study was approved by the Animal Care and Use Committee of Capital Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}